FdaApplication
NDA 216564
Identifiers
- fda_app_no: NDA216564
Properties
| Property | Value |
|---|---|
| applicant_name | DEPROCO INC |
| application_type | NDA |
| approval_date | 2026-03-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLAVALTA | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE | EQ 0.017MG BASE/1.7ML (EQ 0.01MG BASE/ML);34MG/1.7ML (20MG/ML) | SOLUTION;INJECTION |
1 product